VEPT: A Protein Targeted for The Treatment of Angiogenesis-Related Diseases

Target Name: PTPRB

NCBI ID: G5787

PTPRB

VEPT: A Protein Targeted for The Treatment of Angiogenesis-Related Diseases

Protein tyrosine phosphatase (PTP) is a family of enzymes that play a crucial role in various cellular processes. One of the best-known PTPs is vascular endothelial protein tyrosine phosphatase (VEPT), which is a protein that is expressed in the endothelium, the lining of the blood vessels. VEPT is involved in the regulation of several cellular processes, including cell signaling, angiogenesis, and inflammation. Despite its importance, VEPT is still an untargeted drug, and there is a high demand for new drugs that can specifically modulate its activity.

Drugs that target VEPT have the potential to treat a variety of cardiovascular and other diseases. For example, inhibition of VEPT has been shown to improve blood vessel function and reduce the risk of cardiovascular events in animal models of hypertension and heart failure. In addition, Inhibition of VEPT has also been shown to be effective in treating angiogenesis-related diseases, such as cancer.

VEPT is a protein that can be targeted by small molecules, such as inhibitors, due to its unique structure and the various functions it is involved in. One of the main challenges in targeting VEPT is the high degree of interconvertibility between its various forms, which can make it difficult to identify and target specific instances of the protein.

Structure and Function

VEPT is a protein that is composed of a catalytic core and a transmembrane region. The catalytic core consists of a nucleotide base and a protein fragment that includes a catalytic active site, as well as a binding site for small molecules. The transmembrane region consists of a single channel that is formed by the fusion of several transmembrane proteins, including an extracellular domain, a transmembrane domain, and an intracellular domain.

VEPT is involved in the regulation of several cellular processes, including the regulation of cell signaling, angiogenesis, and inflammation. One of the main functions of VEPT is the regulation of angiogenesis, the process by which new blood vessels are formed. VEPT plays a role in this process by regulating the migration and proliferation of endothelial cells, which are the cells that line the blood vessels.

VEPT is also involved in the regulation of cell signaling, including the regulation of cell growth, differentiation, and survival. In addition, VEPT is involved in the regulation of inflammation, including the regulation of the immune response and the regulation of inflammation-related signaling pathways.

VEPT is a protein that can be targeted by small molecules due to its unique structure and the various functions it is involved in. In addition, VEPT has a high degree of interconvertibility between its various forms, which can make it difficult to identify and target specific instances of the protein.

Targeting VEPT

In order to target VEPT, researchers have developed a variety of strategies, including the use of small molecules and antibodies. One of the most promising strategies for targeting VEPT is the use of small molecules that can modulate its catalytic activity or its interaction with other proteins.

One of the most promising small molecules for targeting VEPT is a class of drugs called inhibitors of protein tyrosine phosphatases (IPTs). IPTs are a family of enzymes that are involved in the regulation of several cellular processes, including cell signaling, angiogenesis, and inflammation . In addition, IPTs are known for their ability to selectively modulate the activity of other proteins, making them a promising target for the development of new drugs.

Another strategy for targeting VEPT is the use of antibodies that are specifically designed to recognize and bind to the protein. Antibodies are

Protein Name: Protein Tyrosine Phosphatase Receptor Type B

Functions: Plays an important role in blood vessel remodeling and angiogenesis. Not necessary for the initial formation of blood vessels, but is essential for their maintenance and remodeling. Can induce dephosphorylation of TEK/TIE2, CDH5/VE-cadherin and KDR/VEGFR-2. Regulates angiopoietin-TIE2 signaling in endothelial cells. Acts as a negative regulator of TIE2, and controls TIE2 driven endothelial cell proliferation, which in turn affects blood vessel remodeling during embryonic development and determines blood vessel size during perinatal growth. Essential for the maintenance of endothelial cell contact integrity and for the adhesive function of VE-cadherin in endothelial cells and this requires the presence of plakoglobin (By similarity)

The "PTPRB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTPRB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets